Why Invest In Dupont

Uniquely Positioned for Higher Growth, Higher Value

Since 2009, DuPont’s Board and management have taken decisive action to position the company as a higher growth, higher value, less cyclical company. Today, DuPont’s businesses serve markets where the increasing demand for more and healthier food, renewably sourced materials and fuels, and advanced industrial materials is creating substantial secular growth opportunities. The company’s unique combination of sciences, proven R&D engine, broad global reach, and deep market penetration are distinctive competitive advantages that position DuPont well to continue capitalizing on this enormous potential.

DuPont is well equipped to drive revenue and profit growth through science-based innovation focused on three strategic priorities:

• Agriculture & Nutrition – extending the company’s leadership across the high-value, science-driven segments of the Agriculture and Food value chain;

• Advanced Materials – strengthening the company’s lead as a provider of differentiated, high-value advanced industrial materials; and

• Industrial Biosciences – building transformational new bio-based businesses by combining our world leading science with expertise and resources from the Advanced Materials and Agriculture & Nutrition businesses.

In addition, the company is committed to maintain a strong balance sheet and to return excess cash to shareholders unless there is a compelling opportunity to invest for growth.

Building on more than 200 years of DuPont technology, we aim to capitalize on our unique science to deliver increased returns from our R&D portfolio. Since 2009, we have penetrated key developing markets; refined our business and product portfolio, and we have improved our execution. During the period from 2009 through 2013, we have significantly grown the value of DuPont for our shareholders, almost double the performance of our peers and the S&P 500.

Our portfolio changes are guided by our confidence in the ability of DuPont science to give our customers a competitive edge in the marketplace. This focus guided our decisions to acquire Danisco, divest Performance Coatings, and, in 2013, to announce the separation of Performance Chemicals. This separation, which is anticipated to be a mid-2015 spin-off to shareholders, will create two strong and highly competitive public companies with distinct strategies, compelling product portfolios, and leading market and customer positions. Both companies will be capable of creating significant differentiated value for shareholders.

Going forward, we are in an excellent position to continue to drive revenue and earnings growth through science-based innovation and our significant competitive advantages, while accelerating the achievement of our long-term growth targets.

Superior Returns for Shareholders

Effective execution of this strategy has delivered superior returns for our shareholders and increased the value of DuPont:

• Generated total shareholder return of 214% since year end 20081, compared to 128% for the S&P 500 and 111% for our proxy peers2 during the same period.

• Consistently returned capital to shareholders, more than $10 billion in the form of dividends or share repurchases from 2009 through 2013.

Image of DuPont Pro Forma sales. Click to learn more details about DuPont's financial track record

View our financial profile and track record of successclick red arrow to navigate

DuPont Science Delivers Marketable Solutions for Big Global Challenges

DuPont science positions us to capitalize on significant growth opportunities. We are focused on delivering sustainable and innovative solutions that address the increasing demand for more and healthier food, renewably sourced materials and fuels, and advanced industrial materials. Our expertise across biology, chemistry, materials science and engineering and our unmatched ability to integrate that knowledge gives us a true competitive advantage.

Our superior pipeline, uniquely capable of utilizing multiple scientific disciplines, continues to fuel our future potential. We are applying our science and technology to provide new solutions in food, energy and protection. DuPont continues to add new products which are helping us to meet our commitments to improving food security and protection for people everywhere. In fact, in 2013, about 1750 new products were introduced to the marketplace.

DuPont's Global Reach and Penetration Drives Growth and Opportunity

DuPont has operations in 90 countries around the world. With this extensive presence and an emphasis on rapidly growing emerging markets, DuPont is well positioned to find new demand for existing products, develop localized products responding to specific problems, and create new customer solutions that can be leveraged across our businesses worldwide. In 2013, sales from developing markets represent 33% of the company’s revenue.

Our 12 Innovation Centers enhance the ability of DuPont scientists and engineers to connect directly with customers and partners to discuss product performance, end-user problems and potential solutions. These centers are measurably increasing innovation and accelerating revenue growth, especially in fast-growing markets like Brazil, India and Russia. In 2013, approximately 365 new projects were initiated at Innovation Centers where we realized the strength of our global teams working with our customers one-on-one.

Strong Execution, Superior Returns

In 2013, strong execution continued to produce solid results. The company delivered revenue growth of 3 percent for the year, and operating earnings3 growth of 3 percent compared to the same period in 2012. This result was achieved despite significant price declines and market disruptions in the global TiO2 market which resulted in our Performance Chemicals segment operating earnings declining 45 percent for the year, overshadowing the strong performance in our other businesses.

Aside from Performance Chemicals, our combined businesses in a sluggish global economy grew revenues 5%, while delivering 11% earnings growth -- much more in line with our long-term target growth rates of 7% and 12%. And our operating margins increased about 100 basis points to 16.8%.

Importantly, these businesses delivered solid results by continuing to execute on our strategic and operational priorities.

In January 2014, our Board authorized a $5 billion share repurchase program, with $2 billion expected to be completed in 2014. The new program replaces the existing repurchase program and has no required completion date. The share repurchase program reinforces our ongoing confidence in our plan to continue increasing the value of DuPont for shareholders in 2014 and beyond through both investment in science and innovation and direct return of capital to shareholders.

Building momentum for the future

DuPont is equipped to continue its momentum, delivering value for its shareholders as we deliver inventive products and services to our customers worldwide. Our ability to combine scientific advances and our 200-year base of scientific knowledge makes us an exceptional partner for customers seeking value-added solutions to provide more and healthier food, renewably sourced materials and fuels, and advanced industrial materials. These challenges create opportunities for us and through innovation, execution, global reach, and continuous portfolio assessment, DuPont is seizing these opportunities and aims to deliver attractive returns for its shareholders.

In 2011 we delivered innovation by introducing more than 1,700 new products and a record number of U.S. patent applications. About 85 percent of our R&D resources supported growth areas related to the global megatrends – providing food, energy and protection to a growing population.

Investors can expect attractive long-term growth from innovation driven by megatrends. While we have set aggressive financial targets, DuPont will continue to maintain our culture of accountability and financial discipline.

(1) Datastream as of 12/31/2013, Bloomberg, Capital IQ, FactSet. Proxy Peers and S&P Indices are USD market cap-weighted and assume dividends are re-invested at the closing price applicable on the ex-dividend date from December 31, 2008 to December 31, 2013.
(2) Proxy Peers consists of 3M, Air Products, Baxter Intl, Boeing, Caterpillar, Dow, Emerson, Honeywell, Ingersoll Rand, Johnson Controls, Johnson and Johnson, Kimberly Clark, Merck, Monsanto, Procter and Gamble, Syngenta AG, and United Technologies
(3) Operating earnings excludes significant items and non-operating pension and other postretirement employee benefit costs. A reconciliation of non-GAAP measures to GAAP measures is provided under Key Financials and Filings on this website.

Regulation G

This includes company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company and allows investors to better evaluate the financial results of the company. These measures should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures may not be consistent with similar measures provided by other companies. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K.  These reports, along with reconciliations on non-GAAP measures to GAAP are available on the Investor Center of www.dupont.com under Key Financials & Filings.

Forward Looking Statements

This contains forward-looking statements and provides forward-looking information. All statements that address expectations or projections about the future are forward-looking statements. Some of these statements include words such as “plans,” “expects,” “will,” “anticipates,” "believes," “intends,” and “estimates.” Although they reflect our current expectations, these statements are not guarantees of future performance, but involve a number of risks, uncertainties, and assumptions. Some of which include: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; global economic and capital markets conditions; litigation and environmental matters; changes in laws and regulations or political conditions; business or supply disruptions; ability to protect and enforce the company’s intellectual property rights successful integration of acquired business and separation of underperforming or non-strategic assets; and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff. The company does not undertake to update any forward-looking statements as a result of future developments or new information.

Developing Markets

Total developing markets is comprised of Developing Asia, Developing Europe, Middle East & Africa, and Latin America.  A detailed list of all developing countries is available on the Earnings News Release link on the Investor Center website at www.dupont.com.

DuPont Stock Chart

Stock chart for: DD.  Currently trading at $67.11 with a 52 week high of $68.82 and a 52 week low of $52.02.

Net Sales (Dollars in Billions)

Net Sales Chart

OPERATING EARNINGS PER SHARE 1 (Dollars)

Earnings Per Share

Dividend Payments (Dividends Per Share in Dollars)

Net Sales Chart